Get to know our clinical trials
Trial on the safety and effectiveness of transcranial subthalamotomy with magnetic resonance-guided focused ultrasound (HIFU or MRgFUS) in patients with early Parkinson's disease.
THE AIM OF THE CURRENT STUDY IS TO ANSWER WHETHER ITS EARLY APPLICATION SLOWS DOWN THE CLINICAL PROGRESSION AND, PERHAPS, THE NEURODEGENERATIVE PROCESS OF PARKINSON'S DISEASE.
Status
In recruitment
headquarters
Pamplona
Technical Summary
- SAFETY AND EFFECTIVENESS OF TRANSCRANIAL SUBTHALAMOTOMY WITH MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND (HIFU OR MRGFUS) IN PATIENTS WITH EARLY PARKINSON'S DISEASE.
- Code EudraCT: -
- Protocol number: PD017
- Promoter: InSightec
- Link to Clinical Trials
* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.
Do you want to participate in this trial?
Request an appointment for our specialists to assess whether you qualify for this clinical trial
Do you prefer to send us your reports?
If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.